Gambia

  1. This fact sheet provides an overview of the MVP Access Program, an initiative that grants researchers access to data sets and frozen serum samples collected during the MenAfriVac ® clinical studies in Africa. The fact sheet outlines MenAfriVac's ® development history, qualified uses of data, and how to request data and/or serum access.
    Published: October 2018
    Type: Resource Page
  2. Perspectives from a mom, an immunization manager, and clinical investigators.
    Published: November 2017
    Type: Article
  3. Two clinicians reflect on evaluating early vaccines in The Gambia
    Published: November 2017
    Type: Article
  4. Perspectives from The Gambia’s immunization program manager
    Published: November 2017
    Type: Article
  5. One mother’s story about enrolling her child in a vaccine trial.
    Published: November 2017
    Type: Article
  6. PATH and its partners have been conducting clinical trials to evaluate a pneumococcal vaccine designed to meet needs in low-resource countries.
    Published: November 2017
    Type: Article
  7. Mark Alderson won’t rest easy until he solves one of the biggest problems in global health: a vaccine against pneumonia.
    Published: June 2016
    Type: Article